References
Yang, J.D., Hainaut, P., Gores, G.J., et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 16(10), 589-604. http://doi.org/10.1038/s41575-019-0186-y (2019)
Forner, A., Reig, M. &Bruix, J. Hepatocellular carcinoma. The Lancet. 391(10127), 1301-1314. http://doi.org/10.1016/s0140-6736(18)30010-2 (2018)
Cucchetti, A., Piscaglia, F., Cescon, M., et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 59(2), 300-7. http://doi.org/10.1016/j.jhep.2013.04.009 (2013)
European Association for the Study of the Liver. Electronic address, e.e.e. &European Association for the Study of the, L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 69(1), 182-236. http://doi.org/10.1016/j.jhep.2018.03.019 (2018)
Heimbach, J.K., Kulik, L.M., Finn, R.S., et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 67(1), 358-380. http://doi.org/10.1002/hep.29086 (2018)
Mazzaferro, V., Regalia, E., Doci, R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England journal of medicine. 334(11), 693-699. (1996)
Clavien, P.-A., Lesurtel, M., Bossuyt, P.M.M., et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. The Lancet. Oncology. 13(1), e11-e22. http://doi.org/10.1016/S1470-2045(11)70175-9 (2012)
Marrero, J.A., Kulik, L.M., Sirlin, C.B., et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 68(2), 723-750. http://doi.org/10.1002/hep.29913 (2018)
Mazzaferro, V. Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach. Hepatology (Baltimore, Md.). 63(5), 1707-1717. http://doi.org/10.1002/hep.28420 (2016)
Lim, K.C., Wang, V.W., Siddiqui, F.J., et al. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology. 61(1), 227-37. http://doi.org/10.1002/hep.27135 (2015)
Sapisochin, G. &Bruix, J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 14(4), 203-217. http://doi.org/10.1038/nrgastro.2016.193 (2017)
Tsuchiya, K., Asahina, Y., Tamaki, N., et al. Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Liver Transpl. 20(3), 291-7. http://doi.org/10.1002/lt.23798 (2014)
Doyle, A., Gorgen, A., Muaddi, H., et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3cm in potentially transplantable patients. J Hepatol. 70(5), 866-873. http://doi.org/10.1016/j.jhep.2018.12.027 (2019)
Bruix, J., Sherman, M. &American Association for the Study of Liver, D. Management of hepatocellular carcinoma: an update. Hepatology. 53(3), 1020-2. http://doi.org/10.1002/hep.24199 (2011)
O'Leary, J.G., Lepe, R. &Davis, G.L. Indications for liver transplantation. Gastroenterology. 134(6), 1764-1776. http://doi.org/10.1053/j.gastro.2008.02.028 (2008)
Pompili, M., Saviano, A., de Matthaeis, N., et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. Journal of hepatology. 59(1), 89-97. http://doi.org/10.1016/j.jhep.2013.03.009 (2013)
Cho, J.Y., Choi, M.S., Lee, G.S., et al. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma. Clin Mol Hepatol. 22(4), 477-486. http://doi.org/10.3350/cmh.2016.0048 (2016)
Kim, Y.-s., Lim, H.K., Rhim, H., et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. Journal of hepatology. 58(1), 89-97. http://doi.org/10.1016/j.jhep.2012.09.020 (2013)
Lee, H.Y., Rhim, H., Lee, M.W., et al. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. European radiology. 23(1), 190-197. http://doi.org/10.1007/s00330-012-2561-8 (2013)
Lu, X.-Y., Xi, T., Lau, W.-Y., et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. Journal of cancer research and clinical oncology. 137(4), 567-575. http://doi.org/10.1007/s00432-010-0909-5 (2011)
Mitsuhashi, N., Kobayashi, S., Doki, T., et al. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of gastroenterology and hepatology. 23(7 Pt 2), e189-e197. http://doi.org/10.1111/j.1440-1746.2008.05340.x (2008)
Zheng, Y., Zhu, M. &Li, M. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma. J Cancer Res Clin Oncol. 146(10), 2439-2446. http://doi.org/10.1007/s00432-020-03331-6 (2020)
Tateishi, R., Shiina, S., Yoshida, H., et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology (Baltimore, Md.). 44(6), 1518-1527. (2006)
Ueno, M., Hayami, S., Shigekawa, Y., et al. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers. Journal of hepatology. 63(6), 1352-1359. http://doi.org/10.1016/j.jhep.2015.07.013 (2015)
Grivennikov, S.I., Greten, F.R. &Karin, M. Immunity, inflammation, and cancer. Cell. 140(6), 883-899. http://doi.org/10.1016/j.cell.2010.01.025 (2010)
Cruz, J.C., Watchmaker, J.M., Albin, M.M., et al. Neutrophil/Lymphocyte Ratio Predicts Increased Risk of Immediate Progressive Disease following Chemoembolization of Hepatocellular Carcinoma. Journal of vascular and interventional radiology : JVIR. 30(12), 1887-1892. http://doi.org/10.1016/j.jvir.2019.08.001 (2019)
Mano, Y., Shirabe, K., Yamashita, Y.-I., et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Annals of surgery. 258(2), 301-305. http://doi.org/10.1097/SLA.0b013e318297ad6b (2013)
Huang, J., Zhao, Y., Liao, L., et al. Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer. Biomed Res Int. 2019, 9852782. http://doi.org/10.1155/2019/9852782 (2019)
Wang, S., Deng, Y., Yu, X., et al. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram. Scientific reports. 11(1), 13814. http://doi.org/10.1038/s41598-021-93289-3 (2021)
Wang, C., Zhao, K., Hu, S., et al. A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR. BMC cancer. 20(1), 544. http://doi.org/10.1186/s12885-020-07040-8 (2020)
Rashid, F., Waraich, N., Bhatti, I., et al. A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World journal of surgical oncology. 8, 1. http://doi.org/10.1186/1477-7819-8-1 (2010)
Chen, Y., Yang, Y., Zhang, X.-Y., et al. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation. Cardiovascular and interventional radiology. http://doi.org/10.1007/s00270-021-02872-8 (2021)
Goyal, H. &Hu, Z.D. Prognostic value of red blood cell distribution width in hepatocellular carcinoma. Ann Transl Med. 5(13), 271. http://doi.org/10.21037/atm.2017.06.30 (2017)
Wu, J., Zhang, X., Liu, H., et al. RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection. Clin Biochem. 63, 24-31. http://doi.org/10.1016/j.clinbiochem.2018.11.012 (2019)
Zhang, X., Wang, D., Chen, Z., et al. Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis. Medicine. 99(23), e20638. http://doi.org/10.1097/MD.0000000000020600 (2020)